News
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155] Medicine Not selected 10 April 2025 Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback